Advances in Chronic Kidney Disease
Volume 16, Issue 6 , Pages 511-528 , November 2009

Anabolic Interventions in ESRD

  • Thomas W. Storer, Ph.D.

      Affiliations

    • Corresponding Author InformationAddress correspondence to Thomas W. Storer, PhD, Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, BioSquare III, 670 Albany Street, Boston, MA 02118.

References 

  1. Adams GR, Vaziri ND. Skeletal muscle dysfunction in chronic renal failure: Effects of exercise. Am J Physiol Renal Physiol. 2006;290:F753–F761
  2. Johansen KL, Shubert T, Doyle J, et al. Muscle atrophy in patients receiving hemodialysis: Effects on muscle strength, muscle quality, and physical function. Kidney Int. 2003;63:291–297
  3. Kouidi E, Albani M, Natsis K, et al. The effects of exercise training on muscle atrophy in haemodialysis patients. Nephrol Dial Transplant. 1998;13:685–699
  4. Diesel W, Emms M, Knight BK, et al. Morphologic features of the myopathy associated with chronic renal failure. Am J Kidney Dis. 1993;22:677–684
  5. Fahal IH, Bell GM, Bone JM, et al. Physiological abnormalities of skeletal muscle in dialysis patients. Nephrol Dial Transplant. 1997;12:119–127
  6. Johansen KL. Physical functioning and exercise capacity in patients on dialysis. Adv Ren Replace Ther. 1999;6:141–148
  7. Painter P, Messer-Rehak D, Hanson P, et al. Exercise capacity in hemodialysis, CAPD, and renal transplant patients. Nephron. 1986;42:47–51
  8. Storer TW, Casaburi R, Sawelson S, et al. Endurance exercise training during haemodialysis improves strength, power, fatigability and physical performance in maintenance haemodialysis patients. Nephrol Dial Transplant. 2005;20:1429–1437
  9. Stack AG, Murthy B. Exercise and limitations in physical activity levels among new dialysis patients in the United States: An epidemiologic study. Ann Epidemiol. 2008;18:880–888
  10. Painter P. Exercise in chronic disease: Physiological research needed. Exerc Sport Sci Rev. 2008;36:83–90
  11. Bhasin S, Storer TW. Anabolic applications of androgens for functional limitations associated with aging and chronic illness. Front Horm Res. 2009;37:163–182
  12. Desmeules S, Levesque R, Jaussent I, et al. Creatinine index and lean body mass are excellent predictors of long-term survival in haemodiafiltration patients. Nephrol Dial Transplant. 2004;19:1182–1189
  13. Galvao DA, Newton RU, Taaffe DR. Anabolic responses to resistance training in older men and women: A brief review. J Aging Phys Act. 2005;13:343–358
  14. Kopple JD, Cohen AH, Wang H, et al. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients. J Ren Nutr. 2006;16:312–324
  15. Sakkas GK, Sargeant AJ, Mercer TH, et al. Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Nephrol Dial Transplant. 2003;18:1854–1861
  16. Booth F, Baldwin K. Muscle plasticity: Energy demand and supply processes. In:  Rowell L,  Shepherd J editor. Handbook of Physiology. New York, NY: Oxford University Press; 1996;p. 1075–1123
  17. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin Exp Pharmacol Physiol. 2002;29:218–222
  18. Moore GE, Parsons DB, Stray-Gundersen J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis. 1993;22:277–287
  19. Macdonald JH, Marcora SM, Jibani M, et al. Intradialytic exercise as anabolic therapy in haemodialysis patients—A pilot study. Clin Physiol Funct Imaging. 2005;25:113–118
  20. Konstantinidou E, Koukouvou G, Kouidi E, et al. Exercise training in patients with end-stage renal disease on hemodialysis: Comparison of three rehabilitation programs. J Rehabil Med. 2002;34:40–45
  21. Kopple JD, Wang H, Casaburi R, et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol. 2007;18:2975–2986
  22. Kraemer WJ. Adaptations to resistance training. In:  Ehrman JK editors. ACSM's Resource Manual for Exercise Testing and Prescription (ed 6). Philadelphia, PA: Wolters Kluwer - Lippincott Williams & Wilkins; 2009;p. 489–508
  23. Fiatarone MA, Marks EC, Ryan ND, et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990;263:3029–3034
  24. Panton LB, Golden J, Broeder CE, et al. The effects of resistance training on functional outcomes in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2004;91:443–449
  25. Bhasin S, Calof OM, Storer TW, et al. Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab. 2006;2:146–159
  26. Johansen KL, Painter PL, Sakkas GK, et al. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. J Am Soc Nephrol. 2006;17:2307–2314
  27. Headley S, Germain M, Mailloux P, et al. Resistance training improves strength and functional measures in patients with end-stage renal disease. Am J Kidney Dis. 2002;40:355–364
  28. Nindl BC, Headley SA, Tuckow AP, et al. Igf-i system responses during 12 weeks of resistance training in end-stage renal disease patients. Growth Horm IGF Res. 2004;14:245–250
  29. Cheema B, Abas H, Smith B, et al. Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: The progressive exercise for anabolism in kidney disease (peak) study. Am J Kidney Dis. 2007;50:574–584
  30. Cheema B, Abas H, Smith B, et al. Progressive exercise for anabolism in kidney disease (peak): A randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol. 2007;18:1594–1601
  31. Deligiannis A, Kouidi E, Tassoulas E, et al. Cardiac effects of exercise rehabilitation in hemodialysis patients. Int J Cardiol. 1999;70:253–266
  32. van den Ham EC, Kooman JP, Schols AM, et al. The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients. Transplantation. 2007;83:1059–1068
  33. Deligiannis A. Exercise rehabilitation and skeletal muscle benefits in hemodialysis patients. Clin Nephrol. 2004;61:S46–S50suppl
  34. Kalyani RR, Gavini S, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am. 2007;36:333–348
  35. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82:407–413
  36. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90:678–688
  37. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial. JAMA. 1999;281:1275–1281
  38. Eiam-Ong S, Buranaosot S, Wathanavaha A, et al. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease. J Ren Nutr. 2007;17:173–178
  39. Lowrie EG, Curtin RB, LePain N, et al. Medical outcomes study short form-36: A consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003;41:1286–1292
  40. Hoffman AR, Kuntze JE, Baptista J, et al. Growth hormone (gh) replacement therapy in adult-onset gh deficiency: Effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2048–2056
  41. Lange KH, Isaksson F, Rasmussen MH, et al. Gh administration and discontinuation in healthy elderly men: Effects on body composition, gh-related serum markers, resting heart rate and resting oxygen uptake. Clin Endocrinol (Oxf). 2001;55:77–86
  42. Storer TW, Woodhouse LJ, Sattler F, et al. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab. 2005;90:4474–4482
  43. Burdet L, de Muralt B, Schutz Y, et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997;156:1800–1806
  44. Feldt-Rasmussen B, Lange M, Sulowicz W, et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol. 2007;18:2161–2171
  45. Pupim LB, Flakoll PJ, Yu C, et al. Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients. Am J Clin Nutr. 2005;82:1235–1243
  46. Garibotto G, Barreca A, Russo R, et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest. 1997;99:97–105
  47. Hansen TB, Gram J, Jensen PB, et al. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol. 2000;53:99–107
  48. Kopple JD, Cheung AK, Christiansen JS, et al. opportunity: A randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:1741–1751
  49. Naish PF, Mercer TH, Koufaki P, et al. Vo2peak underestimates physical dysfunction in elderly dialysis patients. Med Sci Sports Exerc. 2000;32:160;abstr
  50. Koufaki P, Mercer TH, Naish PF. Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging. 2002;22:115–124
  51. Mercer TH, Crawford C, Gleeson NP, et al. Low-volume exercise rehabilitation improves functional capacity and self-reported functional status of dialysis patients. Am J Phys Med Rehabil. 2002;81:162–167
  52. Molsted S, Eidemak I, Sorensen HT, et al. Five months of physical exercise in hemodialysis patients: Effects on aerobic capacity, physical function and self-rated health. Nephron Clin Pract. 2004;96:c76–c81
  53. Painter P, Moore G, Carlson L, et al. Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis. 2002;39:257–265
  54. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1094–1105
  55. Baechle T, Earle R, Wathen D. Resistance training. In:  Baechle T,  Earle R editor. Essentials of Strength Training and Conditioning (ed 2). Champaign, IL: Human Kinetics; 2000;p. p 407
  56. Cheema BS, O'Sullivan AJ, Chan M, et al. Progressive resistance training during hemodialysis: Rationale and method of a randomized-controlled trial. Hemodial Int. 2006;10:303–310
  57. Painter PL, Nelson-Worel JN, Hill MM, et al. Effects of exercise training during hemodialysis. Nephon. 1986;43:87–92
  58. Cheema BS, Smith BC, Singh MA. A rationale for intradialytic exercise training as standard clinical practice in ESRD. Am J Kidney Dis. 2005;45:912–916
  59. Horber FF, Thomi F, Casez JR, et al. Impact of hydration status on body composition as measured by dual energy x-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol. 1992;65:895–900
  60. Negri AL, Barone R, Veron D, et al. Lean mass estimation by creatinine kinetics and dual-energy x-ray absorptiometry in peritoneal dialysis. Nephron Clin Pract. 2003;95:c9–c14
  61. Kopple JD, Storer T, Casburi R. Impaired exercise capacity and exercise training in maintenance hemodialysis patients. J Ren Nutr. 2005;15:44–48

PII: S1548-5595(09)00167-0

doi: 10.1053/j.ackd.2009.08.008

Advances in Chronic Kidney Disease
Volume 16, Issue 6 , Pages 511-528 , November 2009

Article Tools